Outcomes from RESONATE Trial in Relapsed CLL

Outcomes from RESONATE Trial in Relapsed CLL

obr

4 months
68 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Paul M.Barr MD Associate Professor of Medicine at Wilmot Cancer Institute explains the results found of the RESONATE Trial that was evaluating ibrutinib versus ofatumumab in relapsed chronic lymphocytic leukemia (CLL).
Up Next Autoplay
ASH 2016 Page 3 Maintenance Therapy in Chronic Lymphocytic Leukemia
ASH 2016 Page 3 Maintenance Therapy in Chronic Lymphocytic Leukemia
Category: Chronic Lymphocytic Leukemia
200 Views
cancergrace 4 months
ASH 2016 Page 2 Update on New Chronic Lymphocytic Leukemia Drugs
ASH 2016 Page 2 Update on New Chronic Lymphocytic Leukemia Drugs
Category: Chronic Lymphocytic Leukemia
91 Views
cancergrace 4 months
CLL, What is the significance of IGHV mutations and how are they assessed
CLL, What is the significance of IGHV mutations and how are they assessed
Category: Chronic Lymphocytic Leukemia
86 Views
cancergrace 4 months
Not Your Fathers CLL with Dr. John Pagel
Not Your Fathers CLL with Dr. John Pagel
Category: Chronic Lymphocytic Leukemia
113 Views
cancergrace 4 months
CLL, Is there a role still for chemo AND who should get chemo
CLL, Is there a role still for chemo AND who should get chemo
Category: Chronic Lymphocytic Leukemia
74 Views
cancergrace 4 months
CLL, FCR vs BR – Is One Better
CLL, FCR vs BR – Is One Better
Category: Chronic Lymphocytic Leukemia
175 Views
cancergrace 4 months
The Role of CAR-T Therapy in B-Cell Lymphomas
The Role of CAR-T Therapy in B-Cell Lymphomas
Category: Chronic Lymphocytic Leukemia
69 Views
obr 4 months
CLL-14 Data Trial in Chronic Lymphocytic Leukemia
CLL-14 Data Trial in Chronic Lymphocytic Leukemia
Category: Chronic Lymphocytic Leukemia
149 Views
obr 4 months
Opinion on Ibrutinib on 1st Line CLL
Opinion on Ibrutinib on 1st Line CLL
Category: Chronic Lymphocytic Leukemia
196 Views
obr 4 months